These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11821742)

  • 1. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation.
    Petit B; Le Meur Y; Jaccard A; Paraf F; Robert CL; Bordessoule D; Labrousse F; Drouet M
    Transplantation; 2002 Jan; 73(2):265-71. PubMed ID: 11821742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorders: determination of donor/recipient origin in a large cohort of kidney recipients.
    Olagne J; Caillard S; Gaub MP; Chenard MP; Moulin B
    Am J Transplant; 2011 Jun; 11(6):1260-9. PubMed ID: 21564528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
    Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
    Schlieper G; Kurschat C; Donner A; Huckenbeck W; Rüdiger T; Sandmann W; Grabensee B; Ivens K; Heering P
    Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin.
    Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN
    Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of paid transplantation abroad: possible donor-origin early multiple myeloma in a renal transplant recipient treated using bortezomib.
    Solak Y; Atalay H; Anil M; Aydogdu I; Tonbul HZ
    Transplant Proc; 2010 Sep; 42(7):2813-5. PubMed ID: 20832595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
    Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
    Weissmann DJ; Ferry JA; Harris NL; Louis DN; Delmonico F; Spiro I
    Am J Clin Pathol; 1995 Jun; 103(6):748-55. PubMed ID: 7785662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
    Khedmat H; Taheri S
    Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
    Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML
    Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
    Goral S; Felgar R; Shappell S
    Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
    Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.